Stay updated with breaking news from Solid Tumor Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genomic Testing Cooperative (GTC) today announced it received CE-IVD marks for its Hematology Profile Plus, Solid Tumor Plus as well as its liquid biopsy profiles for both solid tumors and hematology
About a year ago, Genomic Testing Cooperative received New York State approval and Medicare coverage for the tests.
Genomic Testing Cooperative Hematology Profile Plus, Solid Tumor Profile Plus, and Liquid Biopsy Profiles Receive CE-IVD MarkIRVINE, California, May 25, 2022 / B3C newswire / -- Genomic Testing Cooperative (GTC) today announced it received CE-IVD marks for its Hematology Profile Plus, Solid Tumor Plus as well as its...